Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
- PMID: 9510252
- DOI: 10.1038/32183
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Abstract
CD8+ cytotoxic T lymphocytes (CTLs) mediate resistance to infectious agents and tumours. Classically, CTLs recognize antigens that are localized in the cytoplasm of target cells, processed and presented as peptide complexes with class I molecules of the major histocompatibility complex (MHC). However, there is evidence for an exogenous pathway whereby antigens that are not expected to gain access to the cytoplasm are presented on MHC class I molecules. The most dramatic example is the in vivo phenomenon of cross-priming: antigens from donor cells are acquired by bone-marrow-derived host antigen-presenting cells (APCs) and presented on MHC class I molecules. Two unanswered questions concern the identity of this bone-marrow-derived cell and how such antigens are acquired. Here we show that human dendritic cells, but not macrophages, efficiently present antigen derived from apoptotic cells, stimulating class I-restricted CD8+ CTLs. Our findings suggest a mechanism by which potent APCs acquire antigens from tumours, transplants, infected cells, or even self-tissue, for stimulation or tolerization of CTLs.
Similar articles
-
Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.J Immunol. 1995 Oct 1;155(7):3313-21. J Immunol. 1995. PMID: 7561024
-
Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.Nature. 1999 Mar 4;398(6722):77-80. doi: 10.1038/18038. Nature. 1999. PMID: 10078533
-
Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.Cancer Res. 1999 Sep 15;59(18):4642-50. Cancer Res. 1999. PMID: 10493519
-
Cross-presentation: underlying mechanisms and role in immune surveillance.Immunol Rev. 2005 Oct;207:166-83. doi: 10.1111/j.0105-2896.2005.00301.x. Immunol Rev. 2005. PMID: 16181335 Review.
-
Cross-presentation of antigens by dendritic cells.Crit Rev Immunol. 2002;22(5-6):439-48. Crit Rev Immunol. 2002. PMID: 12803320 Review.
Cited by
-
TIM-3 regulates innate immune cells to induce fetomaternal tolerance.J Immunol. 2013 Jan 1;190(1):88-96. doi: 10.4049/jimmunol.1202176. Epub 2012 Nov 23. J Immunol. 2013. PMID: 23180822 Free PMC article.
-
Mechanisms of action of therapeutic antibodies for cancer.Mol Immunol. 2015 Oct;67(2 Pt A):28-45. doi: 10.1016/j.molimm.2015.04.002. Epub 2015 Apr 23. Mol Immunol. 2015. PMID: 25911943 Free PMC article. Review.
-
Advances in Molecular Imaging Strategies for In Vivo Tracking of Immune Cells.Biomed Res Int. 2016;2016:1946585. doi: 10.1155/2016/1946585. Epub 2016 Sep 20. Biomed Res Int. 2016. PMID: 27725934 Free PMC article. Review.
-
Intradermal electroporation of naked replicon RNA elicits strong immune responses.PLoS One. 2012;7(1):e29732. doi: 10.1371/journal.pone.0029732. Epub 2012 Jan 4. PLoS One. 2012. PMID: 22238645 Free PMC article.
-
Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection.J Clin Invest. 2015 Feb;125(2):752-68. doi: 10.1172/JCI77014. Epub 2014 Dec 22. J Clin Invest. 2015. PMID: 25562320 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous